Skip to main content
. 2017 Jul 11;8:410. doi: 10.3389/fphar.2017.00410

Figure 4.

Figure 4

Forest plot comparing 30-day all-cause mortality in patients randomized to bivalirudin vs. heparin with provisional or routine GPI use.